Prevalence of rectal colonization with multidrug-resistant enterobacteriaceae among international patients hospitalized at mayo clinic, Rochester, Minnesota

Infection Control and Hospital Epidemiology

Volumn 35, Issue 2, 2014, Pages 182-186

  Vasoo, Shawn ^a   Madigan, Theresa ^a   Cunningham, Scott A ^a   Mandrekar, Jayawant N ^a   Porter, Stephen B ^b   Johnston, Brian ^b   Sampathkumar, Priya ^a   Tosh, Pritish K ^a   Johnson, James R ^b   Patel, Robin ^a   Banerjee, Ritu ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; CHILD; ENTEROBACTERIACEAE INFECTIONS; EPIDEMIOLOGY; FEMALE; HOSPITAL PATIENT; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; MIGRATION; MULTIDRUG RESISTANCE; PRESCHOOL CHILD; PREVALENCE; RECTUM; RISK FACTOR; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; MINNESOTA; PREVALENCE; RECTUM; RISK FACTORS; TRANSIENTS AND MIGRANTS; YOUNG ADULT;

EID: 84892696779     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/674853     Document Type: Article

References (12)

1. Centers for Disease Control and Prevention (CDC) Health Alert Network. CDC Health Advisory: New Carbapenem-Resistant Enterobacteriaceae Warrant Additional Action by Healthcare Providers. Atlanta: CDC, 2013. http://www.bt.cdc.gov/HAN/han00341.asp. Accessed March 6, 2013.
2. Vasoo S, Cunningham SA, Kohner PC, Lolans K, Hayden MK, Patel R. Rapid and direct real-time detection of blaKPC and blaNDM from surveillance samples. J Clin Microbiol 2013;51:3609-3615.
3. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-281.
4. Johnson JR, Urban C, Weissman SJ, et al. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25: H4) and blaCTX-M-15 among extended-spectrum-b-lactamaseproducing E. coli from the United States, 2000 to 2009. Antimicrob Agents Chemother 2012;56:2364-2370.
5. Weissman SJ, Johnson JR, Tchesnokova V, et al. High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl Environ Microbiol 2012;78:1353-1360.
6. Pitout JD, Campbell L, Church DL, Gregson DB, Laupland KB. Molecular characteristics of travel-related extended-spectrumbeta-lactamase-producing Escherichia coli isolates from the Calgary Health Region. Antimicrob Agents Chemother 2009;53:2539-2543.
7. Centers for Disease Control and Prevention. Carbapenemresistant Enterobacteriaceae containing New Delhi metallo-betalactamase in two patients-Rhode Island, March 2012. MMWR Morb Mortal Wkly Rep 2012;61:446-448.
8. Centers for Disease Control and Prevention. Notes from the field: hospital outbreak of carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-beta-lactamase- Denver, Colorado, 2012. MMWR Morb Mortal Wkly Rep 2012; 62:108.
9. Lowe CF, Kus JV, Salt N, et al. Nosocomial transmission of New Delhi metallo-beta-lactamase-1-producing Klebsiella pneumoniae in Toronto, Canada. Infect Control Hosp Epidemiol 2013; 34:49-55.
10. Gardam MA, Burrows LL, Kus JV, et al. Is surveillance for multidrug-resistant Enterobacteriaceae an effective infection controlstrategy in the absence of an outbreak? J Infect Dis 2002;186: 1754-1760.
11. Lowe CF, Katz K, McGeer AJ, Muller MP. Efficacy of admission screening for extended-spectrum beta-lactamase producing Enterobacteriaceae. PLoS One 2013;8:e62678.
12. Jamal W, Rotimi VO, Albert MJ, Khodakhast F, Udo EE, Poirel L. Emergence of nosocomial New Delhi metallo-beta-lactamase1 (NDM-1)-producing Klebsiella pneumoniae in patients admitted to a tertiary care hospital in Kuwait. Int J Antimicrob Agents 2012;39:183-184.